Tag Archives: license

Inventors would own more, were it not for noncompliant Bayh-Dole practice

Posted on March 10, 2023 by Gerald Barnett

I saw this tweet this morning: I agree Inventors should own more, but institutions were/are the heart of Bayh-Dole that (arguably) enables IP-driven startups… this is bc many/most PI inventions would go into a black hole without tech transfer officer … Continue reading →

Posted in Bayh-Dole, Metrics, Patents, Policy | Tagged , , , | Comments Off on Inventors would own more, were it not for noncompliant Bayh-Dole practice

On Technology Transfer Metrics, 2: Management

Posted on July 26, 2020 by Gerald Barnett

There are uses for metrics in business. One is to make management decisions. Consider this repeated bit of nonsense–you can’t manage what you don’t measure. There’s a veneer of truth in that, along the lines of “if you measure it, … Continue reading →

Posted in Metrics, Technology Transfer | Tagged , , | Comments Off on On Technology Transfer Metrics, 2: Management

Bayh-Dole march-in won’t change drug prices but other things might–2

Posted on February 12, 2020 by Gerald Barnett

Now let’s look at alternatives to Bayh-Dole’s march-in procedures to address competition, public access, and prevention of unreasonable use, including price gouging. We will consider two within Bayh-Dole and two outside Bayh-Dole. The Bayh-Dole alternatives are: use the government license … Continue reading →

Posted in Bayh-Dole, high priced drugs, Policy | Tagged , , , , | Comments Off on Bayh-Dole march-in won’t change drug prices but other things might–2

Bayh-Dole march-in won’t change drug prices but other things might–1

Posted on February 11, 2020 by Gerald Barnett

Folks think that somehow Bayh-Dole permits government take over of pharma patents and by doing this, somehow, the price of drugs will necessarily–magically–go down. Let’s work through this idea. Set aside for a moment that many drugs don’t do much … Continue reading →

Posted in Bayh-Dole, high priced drugs, Policy | Tagged , , , , | Comments Off on Bayh-Dole march-in won’t change drug prices but other things might–1

University inventions that aren’t exactly worthless-2

Posted on August 28, 2019 by Gerald Barnett

Companies, it turns out, are pretty good at evaluating inventions that are “worth” something to them. Companies with large research enterprises appear to be less good than others, however. The story at Xerox PARC was that inventors hoped that their … Continue reading →

Posted in Agreements, Policy, Technology Transfer | Tagged , , , , | Comments Off on University inventions that aren’t exactly worthless-2

Institutional Patent Licensing–One of the least “direct” ways to obtain new technology

Posted on January 18, 2017 by Gerald Barnett

A few weeks ago I was involved in a discussion about how a region might import new technology developed at distant universities. One of the participants, with a background in AUTM-style technology transfer, made the off-hand comment that if we … Continue reading →

Posted in Agreements, Bayh-Dole, Freedom, Technology Transfer | Tagged , , , | Comments Off on Institutional Patent Licensing–One of the least “direct” ways to obtain new technology

How can universities demonstrate they aren’t patent trolls?

Posted on November 14, 2016 by Gerald Barnett

Let’s say, just for the sake of argument, that university administrators at places like Caltech don’t want to be labelled patent trolls. What might make it clear that universities are not just one more set of patent trolls? “We’re not … Continue reading →

Posted in Agreements, Commons, Freedom, Policy | Tagged , , , , | Comments Off on How can universities demonstrate they aren’t patent trolls?